Seuraa
Matteo Fassan
Matteo Fassan
University of Padua
Vahvistettu sähköpostiosoite verkkotunnuksessa bz.omceo.it
Nimike
Viittaukset
Viittaukset
Vuosi
Pan-cancer analysis of whole genomes
Nature 578 (7793), 82-93, 2020
17962020
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
G Vlachogiannis, S Hedayat, A Vatsiou, Y Jamin, J Fernández-Mateos, ...
Science 359 (6378), 920-926, 2018
17432018
Whole-genome landscape of pancreatic neuroendocrine tumours
A Scarpa, DK Chang, K Nones, V Corbo, AM Patch, P Bailey, RT Lawlor, ...
Nature 543 (7643), 65-71, 2017
9352017
Micro-RNA profiling in kidney and bladder cancers
F Gottardo, CG Liu, M Ferracin, GA Calin, M Fassan, P Bassi, C Sevignani, ...
Urologic Oncology: Seminars and Original Investigations 25 (5), 387-392, 2007
8092007
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
Y Jiao, TM Pawlik, RA Anders, FM Selaru, MM Streppel, DJ Lucas, ...
Nature genetics 45 (12), 1470-1473, 2013
7262013
MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets
R Baffa, M Fassan, S Volinia, B O'Hara, CG Liu, JP Palazzo, M Gardiman, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2009
6292009
Mismatch repair deficiency, microsatellite instability, and survival: an exploratory analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) trial
EC Smyth, A Wotherspoon, C Peckitt, D Gonzalez, S Hulkki-Wilson, ...
JAMA oncology 3 (9), 1197-1203, 2017
5532017
Gastritis OLGA‐staging and gastric cancer risk: a twelve‐year clinico‐pathological follow‐up study
M Rugge, M de Boni, G Pennelli, M de Bona, L Giacomelli, M Fassan, ...
Alimentary pharmacology & therapeutics 31 (10), 1104-1111, 2010
3632010
Targeted next‐generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas
E Amato, M Molin, A Mafficini, J Yu, G Malleo, B Rusev, M Fassan, ...
The Journal of pathology 233 (3), 217-227, 2014
3592014
Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations
CP Wardell, M Fujita, T Yamada, M Simbolo, M Fassan, R Karlic, P Polak, ...
Journal of hepatology 68 (5), 959-969, 2018
3432018
DNA qualification workflow for next generation sequencing of histopathological samples
M Simbolo, M Gottardi, V Corbo, M Fassan, A Mafficini, G Malpeli, ...
PloS one 8 (6), e62692, 2013
3402013
MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer
N Valeri, C Braconi, P Gasparini, C Murgia, A Lampis, V Paulus-Hock, ...
Cancer cell 25 (4), 469-483, 2014
3262014
The SWI/SNF complex is a mechanoregulated inhibitor of YAP and TAZ
L Chang, L Azzolin, D Di Biagio, F Zanconato, G Battilana, ...
Nature 563 (7730), 265-269, 2018
3082018
Transcriptional addiction in cancer cells is mediated by YAP/TAZ through BRD4
F Zanconato, G Battilana, M Forcato, L Filippi, L Azzolin, A Manfrin, ...
Nature medicine 24 (10), 1599-1610, 2018
2982018
Effect of pathologic tumor response and nodal status on survival in the medical research council adjuvant gastric infusional chemotherapy trial
EC Smyth, M Fassan, D Cunningham, WH Allum, AFC Okines, A Lampis, ...
Journal of Clinical Oncology 34 (23), 2721-2727, 2016
2942016
Gastritis: the histology report
M Rugge, G Pennelli, E Pilozzi, M Fassan, G Ingravallo, VM Russo, ...
Digestive and Liver Disease 43, S373-S384, 2011
2542011
Gastric cancer as preventable disease
M Rugge, RM Genta, F Di Mario, EM El-Omar, HB El-Serag, M Fassan, ...
Clinical Gastroenterology and Hepatology 15 (12), 1833-1843, 2017
2442017
Longitudinal liquid biopsy and mathematical modeling of clonal evolution forecast time to treatment failure in the PROSPECT-C phase II colorectal cancer clinical trial
KH Khan, D Cunningham, B Werner, G Vlachogiannis, I Spiteri, T Heide, ...
Cancer discovery 8 (10), 1270-1285, 2018
2382018
Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation
P Gasparini, F Lovat, M Fassan, L Casadei, L Cascione, NK Jacob, ...
Proceedings of the National Academy of Sciences 111 (12), 4536-4541, 2014
2302014
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups
M Simbolo, M Fassan, A Ruzzenente, A Mafficini, LD Wood, V Corbo, ...
Oncotarget 5 (9), 2839, 2014
2242014
Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.
Artikkelit 1–20